eQ Oyj (HEL:EQV1V)

Revance Therapeutics Revenue

eQ Oyj had revenue of 14.51M EUR in the quarter ending June 30, 2025, a decrease of -19.01%. This brings the company's revenue in the last twelve months to 60.60M, down -13.57% year-over-year. In the year 2024, eQ Oyj had annual revenue of 66.49M, down -7.11%.

• Revenue (ttm): 60.60M
• Revenue Growth: -13.57%
• P/S Ratio: 8.92
• Revenue / Employee: 582.69K
• Employees: 113
• Market Cap: 540.36M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	66.49M	-5.09M	-7.11%
Dec 31, 2023	71.58M	-6.80M	-8.67%
Dec 31, 2022	78.38M	-1.09M	-1.37%
Dec 31, 2021	79.47M	22.25M	38.88%
Dec 31, 2020	57.23M	6.16M	12.06%